Studies have revealed a significant decrease in ALKBH5 and FTO mRNA expression, whereas a marked increase in that of METTL3, the enzyme that activates the NF-κB signaling pathway, thus exacerbating the inflammatory response in patients with RA (153). The gene discussed is METTL3; the disease is rheumatoid arthritis.